by Michael Haynes
Dr. Benigno Agbayani
are trying to scare us
'It's one of the
safest drugs in the world.'
A doctor from the
Philippines strongly defended the
use of Ivermectin for preventing
and treating COVID-19, pointing to "80 clinical studies" which
support his arguments, and alluding to "bias" and conflicts of
interest, which have led medical bodies to be reluctant about
promoting the drug.
Appearing on Philippine
television channel ABS-CBN, Dr. Benigno
Agbayani answered a range of questions about the efficacy and
safety of the drug, as well as the peculiar reticence to recommend
it for treating COVID-19.
Agbayani, the president of Concerned Doctors and Citizens of the
Philippines, revealed that since last year, he had spent over
five hours a day studying scientific literature on all things
pertaining to COVID-19, including the non-effectiveness of
"I think I've read
more than anyone on COVID-19," he stated.
However, Agbayani did not
spend long defending his medical credentials, but instead advocated
the use of Ivermectin by referring to the wealth of scientific
studies with which he was by now very familiar.
He already prescribed
Ivermectin to over 300 of his own patients, but despite the success
he has experienced so far, Agbayani stated that he looks,
"at the success rate
of studies, rather than my personal experience, because that's
where I base my recommendations."
"As much as anecdotal [pieces of evidence] are good, and we have
many, I really prefer that we stick to the science," he said.
"People are trying to scare us from taking Ivermectin. It's one
of the safest drugs in the world."
Mentioning a study from
September 2020, Agbayani stated that Ivermectin had been shown to
"the receptor sites
of the virus onto our cells, therefore blocking it from ever
getting to the cell."
"You have over 26, as of today, randomized control trials
showing effectiveness, even as high as 89% for prevention, and
as high as 80% for treatment.
So I think regardless
of what the other groups are doing, you have so much science
behind it, I do not see why we have to be so concerned."
mentioned Ivermectin in conjunction with accompanying treatments,
but Agbayani noted that even with this, it was possible to prove the
effectiveness of Ivermectin on its own.
Pointing to the
evidence found by Dr.
Tess Lawrie, Agbayani explained that the drugs accompanying
Ivermectin in the studies were there,
"but not all
the time," and that they "have already been proven not to work,
so if you have two drugs given with Ivermectin, and one drug
doesn't work, then you have to conclude that it must be
Ivermectin," which produces the result.
He alluded to the
peculiar antagonism which has been levied against Ivermectin, noting
how skepticism regarding studies promoting Ivermectin is not
mirrored with other drugs:
thing can be said of every drug that we tried. Even people who
are taking Remdesevir, they also try other drugs, and yet you
don't question that."
noted that "most" of the drugs accompanying Ivermectin in the trials
anti-virus [drugs], most of them are supportive of your immune
"There are 80
clinical studies [about the use of Ivermectin]. If the 80
clinical studies show positive response, and maybe about 2% only
showing no response to Ivermectin, in clinical studies, of the
doses that we give, I think that should be enough proof that it
Drawing once more
on the scientific data, Agbayani promoted Ivermectin both as a
prophylactic, and as a treatment once infected with COVID-19.
from "at least 12 clinical studies," of which 3 were randomized,
controlled trials, revealed "an 89% rate of preventing COVID-19."
reluctance regarding Ivermectin
Yet despite this,
medical bodies have been consistently
reluctant to promote the use of Ivermectin, with Big Tech even
weighing in and
deleting videos which defended the drug.
Thanks to the
efforts of the Front Line
Covid-19 Critical Care Alliance (FLCCC), the U.S. National
Institutes of Health (NIH)
upgraded their recommendation for the "miraculous" drug
Ivermectin, making it an option for use in treating COVID-19 within
the United States, but only since January.
two reasons for the global reticence regarding the drug. Dealing
first with the NIH, he suggested that,
"the NIH, the
U.S. I mean, just needs to update their data. I think the last
time they gave an update was February. They said it could be
useful, it may not be useful."
But he also
mentioned that there
deliberate avoidance at properly promoting Ivermectin,
commenting on how the World Health Organization's March 3
recommendation of the drug did not include preventative use, but,
treatment and for severe cases. For severe cases and early
"They did not
include prophylaxis, because I think they're afraid to recommend
it, that's why they did not make a comment," he continued.
"If you look at
the way they studied it, they did include so many other
studies... there seems to be a bias in those recommendations and
we feel that they do not want to look at certain studies
preferentially, and this was observed even before this recent
"There is some
kind of bias going on that we'd like to question. This is the
time in our history when we should look at conflicts of
Such a conflict of
interest could exist in the vaccine company Merck, Agbayani added,
in answer to why the company even
issued a statement advising against the use of Ivermectin for
COVID, despite having developed it some 30 years prior.
This was an,
example of conflict of interest," stated Agbayani.
coming out with a new drug for the early treatment of COVID-19.
How can Merck make money out of Ivermectin, if the patents
already expired in 1996, so even if it tries that, I don't think
they'll make money at all, when so many other companies are
So they have to
put their mouth on their research expenses on their new drug."
joining other vaccine companies in pushing out speedily developed
new drugs, Ivermectin was still being side-lined, although it has
been "used for 25 years," said Agbayani.
Even taking a dose,
"ten times" the
NIH daily recommended amount, would "have no [side] effect."
to other drugs that we are now using that are fairly new, where
you are getting so many reports of side effects.
So it's really
amazing that people still say it's an unsafe drug when it's been
used for 25 years, over 3.7 billion doses have been given."
Dr. Agbayani is by
no means alone in his
promotion of Ivermectin for treating and preventing COVID-19.
in December, intensive care specialist Dr. Pierre Kory, a
founding member of the FLCCC, delivered an impassioned address to
the Senate Homeland Security Committee, defending the,
effectiveness of Ivermectin," and stating that it "basically
obliterates transmission of this virus."
destroys the virus in most people within 48 hours," agreed
fellow panelist Dr. Jean-Jacques Rajter, whose peer-reviewed
study found 60% fewer deaths among patients given the drug.
In fact, the
efficacy of Ivermectin with regard to COVID-19 was
already hinted at in April 2020, when researchers in Australia
pointed to a dramatic effect the drug had on the virus.
"We showed that
a single dose of Ivermectin could kill COVID-19 in a petri dish
within 48 hours, indicating potent antiviral activity," stated
Dr. David Jans, a professor of biochemistry and molecular
biology at Monash University in Melbourne.
Even after just 24
"there was a
really significant reduction" in the virus, added Dr. Kylie
Wagstaff, a senior research fellow in biochemistry and molecular
biology at Monash University.